VANFLYTA® Commercialization Agreement Expands Access to AML Treatment in China

Innovent Biologics and Daiichi Sankyo enter an exclusive agreement to commercialize VANFLYTA®…

Harbour BioMed Announces NMPA Acceptance for the Treatment of Advanced Solid Tumors

Harbour BioMed has announced that China’s National Medical Products Administration (NMPA) has…

Mölnlycke Health Care and Zhende Medical form pioneering joint venture to expand access to advanced wound care solutions in China

Mölnlycke Health Care and Zhende Medical have formed a new joint venture…

China taxes condoms and contraceptive drugs to try to lift falling birth rate

China has ended a long-standing tax exemption on contraceptive drugs and devices…